Articles by James Calloway
Upstart Unveils $1.4B 2026 Revenue Target, Announces CEO Transition
Upstart shares gained slightly premarket after projecting annual revenue of approximately $1.4 billion by 2026 and revealing a leadership change, with co-founder Paul Gu set to become CEO in May.
Spotify Shares Extend Rally on Strong User Growth and Upbeat Profit Outlook
Spotify shares advanced in premarket trading after the company reported record user numbers and issued first-quarter operating income guidance above analyst expectations.
Diageo Shares Edge Up on Insider Purchases Ahead of Key Interim Results
Diageo's stock gained 0.6% in early London trading, building on a prior 3.3% rally, as filings revealed share purchases by the chair and other executives. Investors are focused on interim results scheduled for February 25 for updates on demand and guidance.
Tax Season 2026: Key Deadlines, Refund Timelines, and Penalty Warnings
The IRS sets April 15, 2026 as the federal filing deadline for 2025 returns, with extensions available until October. Most refunds arrive within 21 days, but some credits may delay payments until March.
M&M Q3 Profit Surges 33%, Ashok Leyland Falls Short in Midday Earnings Rush
Mahindra & Mahindra posted strong quarterly earnings driven by SUV and tractor demand, while Ashok Leyland missed estimates due to rising costs. Several firms recorded one-off charges from India's new labor codes.
SSE Stock Holds Near Record Peak as Investors Eye Earnings and Regulatory Outlook
SSE shares trade near a 52-week high, supported by strong volume and director purchases. The utility forecasts robust 2025/26 EPS and increased network investment, though regulatory headwinds loom.
RELX Shares Approach Annual Low Amid AI Concerns Ahead of Earnings
RELX shares fell nearly 3% in early London trading, nearing a 52-week low as investors await annual results. The decline reflects broader anxiety over AI's impact on data and analytics firms.
BAT Chair Term Extended Ahead of Key Earnings Report
British American Tobacco shares gained 0.6% after the board extended Chair Luc Jobin's tenure to April 2028. Investors await the company's annual results, due Thursday.
Unilever Faces Valuation Test Ahead of Earnings Following Deutsche Bank Downgrade
Unilever shares rose 1.53% to 5,244p despite a Deutsche Bank downgrade to 'hold' on valuation concerns. The consumer goods giant reports Q4 and full-year 2025 results on Feb. 12.
NatWest Shares Under Pressure Ahead of Earnings Amid Wealth Deal Scrutiny
NatWest shares fell 2.4% to 605p as investors assess the impact of its £2.7 billion Evelyn Partners acquisition ahead of Friday's annual results.
GSK's RSV Vaccine Advances in Chinese Regulatory Review, Eyes 2027 Decision
GSK's Arexvy RSV vaccine application has been accepted for review by China's drug regulator, with a potential approval decision expected in 2027. The stock edged higher as JPMorgan raised its price target and the company's dividend ex-date approaches.
Barclays Initiates £1 Billion Buyback Amid Profit Growth and U.S. Fee Concerns
Barclays has commenced a £1 billion share repurchase program following a 12% rise in annual pretax profit, while investors monitor regulatory risks to its U.S. card operations.